{"title": "Antibody Responses in Hematopoietic Cell Transplantation Recipients after Vaccination Against Haemophilus Influenzae Type b and Streptococcus pneumoniae", "author": "Yae-Jean Kim; Ji-Young Hwang; Soo-Han Choi; Eunhye Kong; Yanghyun Kim; Ki-Sup Park; Keon-Hee Yoo; Ki-Woong Sung; Hong Hoe Koo; Kyung-Hyo Kim", "url": null, "hostname": null, "description": null, "sitename": "Korean Journal of Pediatric Infectious Diseases", "date": "2014-01-20", "cleaned_text": "1. Centers for Disease Control and Prevention, Infectious Disease Society of America, American Society of Blood and Marrow Transplantation. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000; 49:1-125. CE1-7. 2. Plotkin SA, Walter AO, Paul AO. Vaccines. Vaccination of immunocompromised hosts. 6th ed.St. Louis, Mo.: Elsevier Saunders;2006. p. 1243-56. Ljungman C, Einsele H, Englund J, Machado CM, Storek J, et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant. 2009; 44:521-6. 4. Ljungman P, Engelhard D, de la Camara R, Einsele H, Locasciulli A, Martino R, et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant. 2005; 35:737-46. 5. Tomblyn Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Preface. Bone Marrow Transplant. 2009; 44:453-5. 6. Aucouturier P, Barra A, Intrator L, Cordonnier C, Schulz D, Duarte F, et al. Long lasting IgG subclass and antibacterial polysaccharide antibody deficiency after allogeneic transplantation. Blood. 1987; 70:779-85. 7. Engelhard D, Cordonnier C, Shaw PJ, Parkalli T, Guenther C, Martino R, et al. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol. 2002; 117:444-50. 8. Youssef S, Rodriguez G, RE, Raad II, Safdar A. Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-break-through infections, 1989-2005. Medicine (Baltimore). 2007; 86:69-77. 9. Atkinson K, Storb R, Prentice RL, Weiden PL, Wither-spoon RP, Sullivan K, et al. Analysis of late infections in 89 longterm survivors of bone marrow transplantation. Blood. 1979; 53:720-31. C, Bernaudin JF, Bierling Vernant JP. Pulmonary complications occurring after allogeneic bone marrow transplantation. A study of 130 consecutive transplanted patients. Cancer. 1986; 58:1047-54. 11. Meisel R, Kuypers L, Dirksen U, Schubert R, Gruhn B, Strauss G, et al. Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation. Blood. 2007; 109:2322-6. 12. Pao M, Papadopoulos EB, Chou J, Glenn H, Castro-Malaspina H, Jakubowski AA, al. Response to pneumococcal (PNCRM7) and Haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (allo HCT). Biol Blood Marrow 14:1022-30. 13. Patel SR, Ortin M, Cohen BJ, Borrow R, Irving D, Sheldon J, et al. Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis. 2007; KH, Lim SY. Validation of enzyme immunoassay for the quantitative measurement of human IgG antibodies specific for Haemophilus influenzae Type b capsular polysaccharide. Korean J Pediatr. 2007; 50:143-50. 15. Phipps J, Eby R, Koster M, Madore DV, Qua-taert SA. An serum Peltola Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae Lab Immunol. 2003; 10:514-9. 19. World Health Organization. 2009. Recommendations to assure the quality, safety and efficacy of pneumococcal conjugate vaccines. Available from:. P, Bottiger M, Gahrton G, et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J T, Stenvik M, Kuronen T, Kayhty H, Hovi T, et al. Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. 104:383-8. 22. Chan CY, Molrine DC, Antin JH, Wheeler C, Guinan EC, Weinstein HJ, et al. Antibody responses to tetanus toxoid and Haemophilus influenzae type b conjugate vaccines following autologous peripheral blood stem cell transplantation (PBSCT). Bone Marrow Transplant. 1997; 20:33-8. 23. Hammarstrom Bjorkstrand B, Oberg G, Ljungman P. Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients. Bone Marrow Transplant. 1998; 22:67-71. 24. Molrine DC, Hibberd PL. Vaccines for transplant recipients. Infect Dis Clin North Am. 2001; 15:273-305. HJ, Sallan SE, et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Trans-plantation. 57:677-84. 26. Parkkali L, Eskola J, Ruutu P. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal BMT. Bone Winston DJ, Ho WG, Schiffman G, Champlin RE, Feig SA, Gale RP. Pneumococcal vaccination of recipients of bone marrow transplants. Arch Intern Med. 1983; 143:1735-7. 28. de Roux A, Schmole-Thoma B, Siber GR, Hackell JG, Kuhnke N, al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly elicits improved antibacterial responses R, Zecca M, Pignatti P, Marconi M, et al. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J Clin Immunol. 1995; 15:137-44. G, Ljungman P. Pneumococcal immunity and response to immunization with pneumococcal vaccine in bone marrow transplant patients: the influence of graft versus host reaction. Support Care Cancer. 1993; 1:195-9. 31. Cordonnier C, Labopin M, Chesnel V, Ribaud P, Camara Rde L, Martino R, et al. Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in stem cell transplant recipients: results the EBMT IDWP01 Vaccine. Cordonnier V, Ribaud De La Camara R, Martino R, et al. Randomized study of early versus late immunization with pneumococcal conjugate vaccine after allogeneic stem cell transplantation. Clin Infect Dis. 2009; 48:1392-401. 33. Cordonnier C, Labopin M, Jansen KU, Pride M, Chesnel V, Bonnet E, et al. Relationship between IgG titers and opsonocytophagocytic activity of anti-pneumococcal antibodies after immunization with the 7-valent conjugate vaccine in allogeneic stem cell "}